Experimental obesity drug shows promise in trials, with only mild side effects
Amgen Inc's experimental obesity drug showed promising durability trends in an early trial, paving the way for a larger mid-stage ...
Amgen Inc's experimental obesity drug showed promising durability trends in an early trial, paving the way for a larger mid-stage ...
© 2020 By Khmer Daily News